FDA Import Refusal 799-3103508-2/11/2 — TORRENT PHARMA
The FDA refused shipment 799-3103508-2/11/2 from TORRENT PHARMA (India) on Jul 7, 2021. The refused product falls under Drugs and Biologics — DILTIAZEM HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jul 7, 2021
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62OCC24 DILTIAZEM HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II)
- Charges
- 75